Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Head and Neck Neoplasms 1870Squamous Cell Carcinoma of Head and Neck 1109Nasopharyngeal Carcinoma 535Thyroid Neoplasms 519Mouth Neoplasms 347Oropharyngeal Neoplasms 292Laryngeal Neoplasms 197Carcinoma, Squamous Cell 188Neoplasms 187Breast Neoplasms 183Lung Neoplasms 182Nasopharyngeal Neoplasms 160Thyroid Nodule 154Salivary Gland Neoplasms 135Thyroid Cancer, Papillary 122Neoplasm Metastasis 113Carcinoma, Non-Small-Cell Lung 113Hypopharyngeal Neoplasms 111Melanoma 105Prostatic Neoplasms 99Esophageal Neoplasms 95Colorectal Neoplasms 90Thyroid Diseases 87Uterine Cervical Neoplasms 82Recurrence 81Pancreatic Neoplasms 79Ovarian Neoplasms 70Sarcoma 68Stomach Neoplasms 65Xerostomia 62

Interventions

Thyrotropin Alfa 1Iodine-131 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Low Risk Differentiated Thyroid Cancer × Head & Neck × Clear all
NCT01837745 2023-05-17

ESTIMABL2

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Active not recruiting
776 enrolled
EndocrineHead & Neck

Low Risk Differentiated Thyroid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡